Experienced in Wallerian Degeneration
Experienced in Wallerian Degeneration
Chinese Academy Of Medical Sciences And Peking Union Medical College, 
Beijing, CN 

Overview

Xiaonan Yang practices in Beijing, China. Yang is rated as an Experienced expert by MediFind in the treatment of Wallerian Degeneration. Their top areas of expertise are Progressive Hemifacial Atrophy, Hemangioma, Roberts Syndrome, Wallerian Degeneration, and Osteotomy.

Their clinical research consists of co-authoring 63 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Wallerian Degeneration.

Locations

Chinese Academy Of Medical Sciences And Peking Union Medical College, Beijing, China
Other Locations
State Key Laboratory Of Component Based Chinese Medicine, 10 Poyanghu Road, Tianjin, 301617, China
Chinese Academy Of Medical Sciences And Peking Union Medical College, No.33 Badachu Road, Shijingshan, 100144, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Yang's expertise for a condition
ConditionClose
    View All 10 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile